Gut Microbiome Discovery Guides Cancer Therapies

Researchers have discovered that the ratio of specific gut bacteria can predict the effectiveness of next-generation cancer drugs. This finding could help identify healthy volunteers for fecal microbiome transplants to improve drug responses. The study emphasizes the importance of overall microbial community structure rather than individual species. A new diagnostic tool based on this research may soon help tailor microbiome-targeting therapies to enhance cancer immunotherapy outcomes.